![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Valencia, Spain -- October 02, 2018 -- InvestorsHub NewsWire -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the...
Valencia Spain -- September 05, 2018 -- InvestorsHub NewsWire -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company...
NetworkNewsWire Editorial Coverage: Diagnostic devices are a crucial part of the medical technology sector, and many companies are pressing forward with work in this area. Zenosense, Inc. (OTC:...
Valencia, Spain -- June 19, 2018 -- InvestorsHub NewsWire -- Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology company focused on the...
Zenosense, Inc.: MIDS Hybrid Strip - Successful Initial Test Results VALENCIA, SPAIN -- November 16, 2017 -- InvestorsHub NewsWire -- Zenosense, Inc. (OTC...
VALENCIA, SPAIN -- July 05, 2017 -- InvestorsHub NewsWire -- Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology...
VALENCIA, SPAIN-(NewMediaWire - Jun 15, 2017) - Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology...
In February 2017, Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) announced it will begin providing personalized cannabinoid anti-tumor tests for cancer patients. Cannabics has become one of the few...
VALENCIA, SPAIN--(NewMediaWire - Mar 28, 2017) - Zenosense, Inc. (OTCQB: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the...
VALENCIA, SPAIN--(Marketwired - Mar 10, 2017) - Zenosense, Inc. (OTCQB: ZENO) ("Zenosense," the "Company"), a healthcare technology company primarily focused...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions